Western Blotting Market

Western blotting technique or protein immunoblot is used for detection and quantification of specific protein molecules in the given complex protein sample. A protein molecule is separated on the basis of molecular weight and size, forming bands on the gel, which is further transferred onto the transfer membrane for visualization and analysis of western blot. Western blotting market contributes the major share to the molecular diagnostics market in terms of revenue. Molecular diagnostics include various analytical techniques used in the field of proteomics and genomics. Western blotting technique is considered as the gold standard for the diagnosis of HIV. Western blotting, due to its high specificity and reproducibility, is used as a confirmatory test for the diagnosis of HIV. 

According to the World Health Organization (WHO), it is estimated that in 2013, only 51% of the people with HIV knew about their syndrome status. The major reason for low diagnosis of HIV is attributed to fear of being positively diagnosed with HIV and confidentiality issues related to testing results. As per the statistics released by the joint United Nations program on HIV/AIDS, in 2013, around 35.2 Mn HIV cases were recorded with two million new cases being detected in 2014, taking the combined total for both years to 37.2 Mn. Wide application of western blotting technique in various fields such as scientific research, medical diagnostics, food & beverages industry, agricultural, and other applications is fueling the growth of the western blotting market globally. 

The western blotting market is segmented as follows:

• Western blotting, by product
• Western blotting, by application
• Western blotting, by end use
• Western blotting, by region

This report covers the global western blotting market performance in terms of revenue contribution. This section also includes PMR analysis of key trends, drivers, restraints, and opportunities that are influencing the global western blotting market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights. The report also offers global company share analysis for the year 2014.

By product, the global western blotting market is segmented into electrophoresis blotting systems, reagent kits, and transfer membrane. Of these, reagent kits segment accounts for majority market share currently and is expected to remain the leading segment in terms of volume and value during the forecast period. Transfer membranes segment is expected to expand in terms of value and volume, but at a relatively slower pace as compared to other segments. Electrophoresis blotting systems segment is expected to register higher CAGR in terms of value and volume over the forecast period as compared to other segments. 

By end user, the global western blotting market is segmented into diagnostics laboratories, research institutes, and pharmaceuticals and biotechnology companies. Pharmaceuticals and biotechnology companies segment dominated the western blotting market in 2014 as compared to other segments. However, research institutions segment is projected to register a higher CAGR over the forecast period as compared to other segments mainly due to continuous research work in the field of proteomics. Diagnostics laboratories segment accounted for least share in the global western blotting market in terms of revenue and volume in 2014, and the trend is expected to continue till 2021. Usage of western blotting technique is expected to expand in the diagnostics laboratories and research institutions segments by the end of 2021.

By region, North America is expected to remain the market leader in the western blotting market, mainly due to the availability of sufficient funds to pursue research work in the field of proteomics, increasing investment in R&D initiatives by various pharmaceuticals and biotechnology companies. Revenue from the market in APAC is projected to increase at a significant pace, mainly due to large population base and increasing awareness amongst physicians regarding the need for early detection of HIV. The market in Latin America and North America are expected to follow APAC in terms of value during the forecast period. MEA market is relatively untapped, hence representing the vast potential for various companies in this region. The high price of products and availability of advanced technology is an issue in certain regions. 

Western blotting technique or protein immunoblot is used for detection and quantification of specific protein molecules in the given complex protein sample. A protein molecule is separated on the basis of molecular weight and size, forming bands on the gel which is further transferred onto the transfer membrane for visualization and analysis of the western blot. Western blotting market contributes a major share in the molecular diagnostics market in terms of revenue. Molecular diagnostics include various analytical techniques used in the field of proteomics and genomics. 

Increasing prevalence of HIV across the globe, expanding the application of western blotting in the field of proteomics and increased investment in the R&D by various pharmaceuticals and biotechnology companies are major factors leading to increased demand for western blotting, thereby fuelling the growth of the western blotting market. The emergence of alternative techniques for the detection of protein and a high price of products are few factors expected to hamper the growth of the global western blotting market. Major trends in the western blotting market include increased adoption of the automated techniques, introduction of advanced imaging software for analysis of western blot results, and consistent investment in research and development and a surge in acquisitions and mergers.

The global western blotting market was valued at US$ 510.1 Mn in 2014. The western blotting market accounted for 25% of global molecular diagnostics market in 2014 and was valued at US$ 510.1 Mn. Revenue contribution by western blotting market to the global molecular diagnostics market is expected to increase to US$ 725.0 Mn by the end of 2021, expanding at a CAGR of 5.4% in terms of value during 2015–2021. The increasing prevalence of HIV and continuous research in the field of proteomics are expected to positively affect the growth of the western blotting market across the globe.

Key market players covered in this report are Thermo Fisher Scientific, Inc., GE Healthcare, Hoffmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation (ProteinSimple Inc.), and Advansta, Inc. Major players in western blotting market focus on enhancing their global and regional presence through strategic acquisitions and mergers, and operational expansion.

Key market players covered in this report include:

• Thermo Fisher Scientific, Inc.
• GE Healthcare.
• Hoffmann-La Roche Ltd.
• Danaher Corporation (Lumigen, Inc.)
• EMD Millipore Corporation.
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc., LI-COR, Inc.
• Bio-Techne Corporation (ProteinSimple Inc.)
• Advansta, Inc.
• Other.

These players have been profiled on the basis of various attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.